BRAF GENE MUTATION
Clinical trials for BRAF GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF GENE MUTATION trials appear
Sign up with your email to follow new studies for BRAF GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: early trial tests targeted drug combo
Disease control TerminatedThis early-stage clinical trial tested a new drug called DCC-3084, both alone and combined with other cancer therapies, for people with advanced solid tumors driven by specific genetic mutations. The study aimed to find a safe dose and see if the treatment could shrink tumors in …
Matched conditions: BRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New oral cancer pill tested in patients who have run out of options
Disease control TerminatedThis early-stage study tested a new oral medication called IK-595 in adults with advanced solid tumors that have specific genetic changes (RAS or RAF mutations) and no remaining standard treatment options. The main goals were to find a safe dose, see how the body processes the dr…
Matched conditions: BRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC